BREAST CANCER BASE

Breast cancer endocrine therapy Breast cancer endocrine therapy, it refers primarily to drug treatment. Endocrine therapy are two ways : One, the use of antagonists to es...

Femara clinical research process active endocrine therapy for breast cancer Aromatase inhibitors (ve class -- AI) is the study of endocrine therapy for breast cancer the most active part. With the third generation o...

No chemotherapy directly with Femara work? The world at present, after receptor-positive breast cancer patients using complementary therapy — endocrine therapy more effective, if it can first before using six regular cycle of adequate chemotherapy work better.
Surgery has been recycling for many years femara work? Generally speaking after the surgery, first six cycles of chemotherapy, followed by adjuvant endocrine therapy done.
If surgery has been for many years, so now propose to go Femara treatment. Can follow-up observation.

Chemotherapy is used Femara can be used? Chemotherapy is used when sufficient quantities should be completed chemotherapy, the use of endocrine therapy such as letrozole.

How long can use to complete chemotherapy Femara? Generally speaking chemotherapy is a 21-day cycle, six since the end of cycle may begin with endocrine therapy.

The direct use of Femara with tamoxifen good or good? The latest research shows that in postmenopausal patients with early breast cancer after taking femara more significant reduction in recurrent or metastatic breast cancer risk, bring about long-term hope of survival. So can taking letrozole.

Eating can be replaced tamoxifen Femara? May.

Recurrent Femara can be used? If the chemotherapy is doing can use? The transfer of patients relapse if receptor-positive, postmenopausal patients can be used for the treatment of Femara. But not with the chemotherapy joint use. If the chemotherapy is being done now, it should be accurate evaluation of chemotherapeutic effect, if effective chemotherapy to continue chemotherapy; If chemotherapy can switch to Femara stopped chemotherapy treatment; If the disease after treatment to stabilize, according to the patient's physical situation, the economic situation overall arrangements.

Femara can prevent breast cancer recurrence and metastasis? Just completed by independent investigators completed the BIG1-98 clinical trials (letrozole with tamoxifen for early stage breast cancer as compared to the adjuvant treatment of the study) results showed that postmenopausal patients with early breast cancer after taking letrozole more significant reduction in breast cancer recurrence and metastasis of risks, bring about the long-term survival hope.

Not menopause, but can be used receptor-positive? Not receptor-positive postmenopausal patients Generally speaking Femara is not used this kind of drug. If I want to, can do the castration treatment, for example, do ovary removal surgery or medical castration, or using drugs such as Zoladex castration.

But menopause can receptor negative? Postmenopausal prevention of postoperative recurrence and metastasis in patients with Femara if other endocrine therapy must receptor-positive it. But recurrence in postmenopausal patients if you want to use Femara treatment may also one to two months probation, if effective or stable disease, it can continue to do so; If lesions progress worsens, the immediate cessation changed to try other treatment.

Chemotherapy and tamoxifen also can be used? Chemotherapy and tamoxifen can apply the same principle, because tamoxifen make tumor cells in the inactive state, the cells sensitive to chemotherapy, meaning the two combined will have negative effects on results. Therefore, these two should be separated from drug use. For the prevention of postoperative recurrence and metastasis of breast cancer patients, it should be used first six to eight cycles of chemotherapy enough, and then began to use tamoxifen; Already recurrence and metastasis in patients speaking, it should be separated from chemotherapy with tamoxifen use, separate evaluation of efficacy. After an ineffective runs with another treatment.

Special to fun, fun-law, tamoxifen and letrozole any different? Ahead of the three-estrogen antagonist, breast cancer cells occupy the estrogen receptor. So estrogen can not stimulate the growth of tumors and treatment play a role. Femara is cut off postmenopausal women estrogen source of the drug. Older women in the estrogen in vivo by androgen into one. Femara and the metandienone cut off such a transformation can play a role in treatment.

What is the endocrine treatment, which is preferable to patients with breast cancer endocrine therapy The breast itself is an endocrine organ, the incidence of breast cancer and the body endocrine dysfunction. The endocrine therapy in breast ...

Hormone replacement therapy and breast cancer Hormone replacement therapy is developed in recent years, in the field of gynecology and obstetrics increasingly extensive application of a...

Hormonal therapy for breast cancer In the treatment of breast cancer, in addition to surgery, radiation, anti-cancer drugs and herbs, there is a hormonal therapy, according t...

Breast cancer endocrine therapy option The advantages of endocrine therapy Practice has proved that even breast cancer patients after surgery no visible clinical metastases, but...

Hormonal therapy for breast cancer merits We need to first understand the endocrine therapy is a clear mechanism, blocking estrogen on tumor growth stimulating effect on normal cells...

2006 NCCN guidelines for advanced or recurrent breast cancer endocrine therapy For ER / PR positive only bone / tissue transfer or asymptomatic visceral metastasis in patients with breast cancer, dealing with the follow...

Breast cancer endocrine treatment which?

Drug treatment of endocrine characteristics of